To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
GTCR-backed Marvai goes public
Maravai LifeSciences, a provider of life science reagents and services to researchers and biotech companies, has raised $1.62 billion for its IPO after pricing its 60 million shares at $27 per share.
